Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers | Synapse
August 15, 2024
Supplementary Figure S5 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Absolute numbers of T cells and IL-18 concentrations during manufacturing
Preguntar a la IA
Me gusta
Guardar
Compartir
Preguntar a la IA
Me gusta
Guardar
Compartir
Cite This Study
Fischer‐Riepe et al. (Thu,) studied this question.